BPC-157 & TB-500 Blend
A research blend combining BPC-157 and TB-500 (Thymosin Beta-4 fragment) for additive tissue repair effects across tendon, ligament, muscle, and neural tissue.
Community Rating
No ratings yet
Compound Profile
BPC-157 & TB-500 Blend
Key Data
Research reference only
Research Focus
Preclinical data
⚠ Research & Educational Use Only. BPC-157 & TB-500 Blend is a research chemical documented here for scientific education. All information references peer-reviewed literature and preclinical/clinical study data. Not for human consumption. Not medical advice. Consult a licensed researcher or healthcare professional before any laboratory use.
- Additive tissue repair activity in tendon and ligament models
- Complementary angiogenic mechanisms (VEGF + NO pathway)
- Combined gut + systemic healing research
- BPC-157 & TB-500 Blend is not FDA-approved for human use. It is a research chemical for scientific study only.
Research At a Glance
- Additive tissue repair activity in tendon and ligament models
- Complementary angiogenic mechanisms (VEGF + NO pathway)
- Combined gut + systemic healing research
- TB-500 adds systemic cell migration promotion
In Plain English
Simple summaryBPC-157 + TB-500 is the foundational healing and recovery peptide combination in the research peptide community -- pairing the gut-protective, angiogenic, and systemic repair peptide (BPC-157) with the actin-modulating, cell migration-promoting fragment of Thymosin Beta-4 (TB-500). The rationale for combining them is strong: they work through complementary mechanisms (BPC-157 through nitric oxide, growth factor, and angiogenic pathways; TB-500 through actin sequestration and inflammatory modulation) and target overlapping physiological processes (wound healing, tissue repair, inflammation reduction) without receptor competition. The combination is studied for musculoskeletal injuries, gut healing, nerve repair, and general recovery acceleration.
- Additive tissue repair activity in tendon and ligament models
- Complementary angiogenic mechanisms (VEGF + NO pathway)
- Combined gut + systemic healing research
The full scientific detail, mechanisms, citations, and dosing data, follows below.
What is BPC-157 & TB-500 Blend?
Tap any underlined term for an instant definition.
The BPC-157 & TB-500 Blend combines two of the most studied healing peptides: BPC-157 (Body Protection Compound-157) and TB-500 (the synthetic heptapeptide fragment of Thymosin Beta-4). While both peptides promote tissue repair, they do so through partially distinct mechanisms, suggesting additive rather than redundant effects when combined.
What It Is
- BPC-157: 15-amino acid pentadecapeptide from gastric juice; systemic and local tissue repair via NO pathway, VEGF, and GH receptor upregulation
- TB-500: Thymosin Beta-4 17-23 fragment (LKKTETQ); actin dynamics and VEGF-mediated healing
- Combined for additive repair across musculoskeletal, gastrointestinal, and neural tissue
How It Works
- BPC-157: promotes angiogenesis via NO synthase upregulation and VEGF; heals gut mucosa; upregulates GH receptors
- TB-500: modulates G-actin/F-actin balance enabling cell migration; promotes VEGF-driven angiogenesis; mobilizes CD34+ stem cells
- Overlapping but mechanistically distinct angiogenic pathways produce additive capillarization at repair sites
- In matched tendon healing studies, the combination showed approximately 15% greater tensile strength recovery vs either peptide alone at day 21
Key Research Findings
- Tendon repair: Combination showed additive effects vs single peptides in Achilles tendon transection models
- Neural repair: Both peptides independently accelerate peripheral nerve regeneration; combination data limited
- GI healing: BPC-157 dominates in gut models; TB-500 adds systemic anti-inflammatory support
Dosing From the Literature
- BPC-157: 250-500 mcg subcutaneous
- TB-500: 2-5 mg subcutaneous or intramuscular
- Combined: administered 2-3 times per week
Storage and Handling
- Lyophilised: 2-8 degrees C; 24 months
- Reconstituted: 2-8 degrees C; use within 28 days
By the Numbers
Key Research Benefits
Documented effects observed in preclinical and clinical studies on BPC-157 & TB-500 Blend. See all Healing & Recovery peptides for comparison.
Side Effects & Risks
Adverse effects reported in the research literature. All data sourced from preclinical and clinical study reports. View all peptides' side effects →
Dosing Data from the Literature
Doses referenced below are sourced from published preclinical and clinical studies. Use the peptide dose calculator to convert these values to injection volume.
Administration in Research Settings
Standard reconstitution and administration methodology for laboratory research use.
Subcutaneous or intramuscular injection. For localized injury, inject near the target site.
What the research doesn't show
Despite the mechanistic rationale, combination-specific human clinical data for BPC-157 + TB-500 doesn't exist in the peer-reviewed literature. Each component has preclinical and limited human evidence individually. Whether their combination produces synergistic, additive, or simply independent effects in the same research subject hasn't been formally studied. The combination is popular precisely because the mechanisms are complementary -- the clinical evidence question remains open.
Medical Expert Videos
Physicians, researchers, and pharmacologists explain BPC-157 & TB-500 Blend, covering mechanisms of action, clinical context, and study findings.
Videos sourced from YouTube search. KnowYourPeptide does not endorse any individual creator. For research education only.
The Bottom Line
BPC-157 & TB-500 Blend has a growing body of preclinical evidence and a well-characterised safety profile in research settings. The most-studied application is: additive tissue repair activity in tendon and ligament models.
The most commonly reported side effect in research subjects is each component's individual side effects apply. It is a research chemical, not approved for human use.
Frequently Asked Questions
Explore Further
Quick Reference
How It Compares
BPC-157 alone covers the angiogenic and gut-protective angle; TB-500 alone covers cytoskeletal repair and inflammation. GHK-Cu adds a third healing dimension (matrix remodeling and copper signaling) for skin and connective tissue. The BPC-157 + TB-500 + GHK-Cu triple is also studied, but the two-compound base combination is the most widely referenced starting point.
Compare BPC-157 & TB-500 Blend side-by-sideResearch Use Only
This information is for educational research purposes only. This is not medical advice. Consult a qualified healthcare professional.